{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-087921","form_type":"8-K","ticker":"RAPP","cik":"0002012593","company_name":"Rapport Therapeutics, Inc.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.682429+00:00","generated_at":"2026-05-19T03:40:00.935714+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Rapport Therapeutics stockholders re-elect three Class I directors and ratify PwC as auditor","bullets":["Reid Huber, Ph.D., John Maraganore, Ph.D., and Wendy B. Young, Ph.D. elected as Class I directors for terms expiring 2028.","Director votes: Huber 31,146,580 for; Maraganore 31,222,571 for; Young 31,783,990 for.","Ratification of PricewaterhouseCoopers LLP as independent auditor passed with 32,804,657 votes for, 112,489 against.","Meeting held June 17, 2025; 36,497,555 shares outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-087921","json":"https://secwatch.observer/filing/0000950170-25-087921.json","markdown":"https://secwatch.observer/filing/0000950170-25-087921.md","text":"https://secwatch.observer/filing/0000950170-25-087921.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2012593/000095017025087921/0000950170-25-087921-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2012593/000095017025087921/rapp-20250617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T03:40:00.935714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}